BioRestorative Therapies announces 1-for-20 reverse stock split to regain Nasdaq compliance

BioRestorative Therapies, Inc.

1-for-20 reverse split effective 4:30 p.m. ET Sept 7, 2026; trading starts Sept 8, 2026 on Nasdaq under BRTX with new CUSIP 090655705.
Outstanding shares reduced from 27,622,556 to ~1,381,128; authorized shares cut from 1.5B to 75M.
Board approved split without stockholder approval under Nevada law; fractional shares rounded up to whole share.
Split aims to regain compliance with Nasdaq $1.00 minimum bid price rule (Listing Rule 5550(a)(2)).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.